PUBLISHER: The Business Research Company | PRODUCT CODE: 1945417
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945417
Intrapartum monitoring devices are specialized medical instruments designed to continuously track the health of both the mother and fetus during labor and delivery. These tools ensure the safety of both mother and baby by providing real-time data that assists healthcare providers in making informed decisions.
The primary types of intrapartum monitoring devices are monitors and electrodes. Monitors are devices used during labor and delivery to continuously track the fetal heart rate and uterine contractions. These devices can employ either invasive or non-invasive methods and are utilized by various end users, including hospitals, maternity centers, and others.
Tariffs have created cost pressures in the intrapartum monitoring devices market by increasing duties on electronic components, sensors, electrodes, and monitoring equipment. These impacts have raised manufacturing and procurement costs, particularly affecting fetal monitors and integrated maternal monitoring systems, with north america and asia-pacific regions experiencing higher exposure due to reliance on imported medical electronics. Hospitals and maternity centers have faced higher equipment costs, influencing purchasing decisions. On the positive side, tariffs have encouraged local manufacturing, regional sourcing of components, and investments in domestic production capabilities, supporting long-term supply chain resilience.
The intrapartum monitoring devices market research report is one of a series of new reports from The Business Research Company that provides intrapartum monitoring devices market statistics, including intrapartum monitoring devices industry global market size, regional shares, competitors with a intrapartum monitoring devices market share, detailed intrapartum monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the intrapartum monitoring devices industry. This intrapartum monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intrapartum monitoring devices market size has grown strongly in recent years. It will grow from $2.31 billion in 2025 to $2.47 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising institutional childbirth rates, increasing awareness of maternal and fetal safety, expansion of hospital maternity infrastructure, growing prevalence of high-risk pregnancies, rising adoption of electronic fetal monitoring.
The intrapartum monitoring devices market size is expected to see strong growth in the next few years. It will grow to $3.19 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for advanced maternity care, growing focus on reducing maternal and neonatal mortality, rising preference for continuous labor monitoring, expanding access to skilled birth facilities, increasing healthcare investment in obstetric care. Major trends in the forecast period include growing adoption of continuous fetal and maternal monitoring, increasing preference for non-invasive intrapartum monitoring methods, rising use of integrated fetal and maternal monitoring systems, expansion of intrapartum monitoring in high-risk pregnancies, growing focus on real-time labor monitoring for improved outcomes.
The increasing prevalence of gynecological diabetes is expected to drive the growth of the intrapartum monitoring device market. Gynecological diabetes, also referred to as gestational diabetes mellitus (GDM), is a condition marked by elevated blood sugar (glucose) levels that occur during pregnancy and usually resolve after childbirth. The rise in gynecological diabetes cases is largely due to the growing rates of obesity and sedentary lifestyles. Intrapartum monitoring devices are used in the management of gynecological diabetes to continuously track fetal heart rate and uterine contractions, ensuring early detection and effective management of potential complications during labor and delivery. For example, in March 2024, a report from the Government of the United Kingdom revealed that, in March 2023, the percentage of individuals with type 1 diabetes in England receiving 8 care processes at GP practices participating in the NDA increased to 43.8%, up from 35.2% the previous year.
Rising healthcare expenditure is expected to drive growth in the intrapartum monitoring devices market. Healthcare expenditure refers to the total spending on medical services, treatments, and health-related resources within a given period. This spending is increasing due to an aging population, which raises demand for medical services, long-term care, and age-related treatments, collectively placing greater financial pressure on healthcare systems. Intrapartum monitoring devices support this growth by enabling continuous fetal and maternal monitoring during labor, reducing complications, improving patient outcomes, and optimizing resource utilization, thereby encouraging investment in advanced perinatal care technologies. For example, in April 2025, the American Medical Association, a US-based professional association, reported that in 2023, health spending in the U.S. rose by 7.5%, reaching $4.9 trillion, or $14,570 per person, a significant increase compared to the 4.6% growth recorded in 2022. This rising expenditure is therefore driving the expansion of the intrapartum monitoring devices market.
Leading companies in the intrapartum monitoring device market are focusing on developing innovative products, such as wireless and belt-free designs, to maintain their market position. These designs enable unobstructed movement and increased comfort for the mother while ensuring continuous monitoring of fetal heart rate and uterine contractions. For example, in February 2024, GE HealthCare Technologies Inc., a US-based medical technology company, received clearance for its Novii+ Wireless Maternal and Fetal Monitoring Solution. This approval allows the device to monitor approximately 95% of all eligible births in the United States. The Novii+ system is designed for use with pregnant patients at or beyond 34 weeks and provides noninvasive monitoring of fetal heart rate, maternal heart rate, and uterine activity. Its wireless and belt-free design enhances mobility and aims to improve the comfort and experience of expectant mothers during labor. The device also features an advanced algorithm known as cross-check artifact reduction, which enhances the accuracy and reliability of the data collected.
Major companies operating in the intrapartum monitoring devices market are Cardinal Health Inc, Medtronic PLC, Fujifilm Holdings Corporation, Philips Healthcare, GE HealthCare Technologies Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd, Dragerwerk AG & Co. KGaA, CooperSurgical Inc., Spacelabs Healthcare, Nihon Kohden Corporation, Contec Medical Systems Co Ltd., Mediana Co Ltd., Natus Medical Incorporated, EDAN Instruments Inc., Guangdong Biolight Meditech Co. Ltd, Dixion Vertrieb medizinischer Gerate GmbH, Bionet America Inc., Shenzhen Bestman Instrument Co Ltd., Huntleigh Healthcare Limited, Neoventa Medical AB, Trismed Co Ltd.
North America was the largest region in the intrapartum monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intrapartum monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the intrapartum monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The intrapartum monitoring devices market consists of sales of electronic fetal monitors (EFMs), tocodynamometers, doppler ultrasound devices, and telemetry systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intrapartum Monitoring Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses intrapartum monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for intrapartum monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intrapartum monitoring devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.